Clinical response of urinary tract infections treated by elkosin, gantrisin, triple sulfa or triple sulfa-achromycin.
D004338:Drug Combinations; D006801:Humans; D013411:Sulfadiazine; D013416:Sulfamerazine; D013418:Sulfamethazine; D013443:Sulfisomidine; D013444:Sulfisoxazole; D013449:Sulfonamides / Q000627:therapeutic use*; D013752:Tetracycline / Q000627:therapeutic use*; D014552:Urinary Tract Infections; D000096926:Benzenesulfonamides
D004338:Drug Combinations; D013411:Sulfadiazine; D013416:Sulfamerazine; D013418:Sulfamethazine; D013443:Sulfisomidine; D013444:Sulfisoxazole; D013449:Sulfonamides; D013752:Tetracycline; C014873:trisulfapyrimidine; D000096926:Benzenesulfonamides
SULFONAMIDE MIXTURES/therapeutic use; TETRACYCLINE/therapeutic use; URINARY TRACT/infections